001     275887
005     20250126000513.0
024 7 _ |a 10.1111/ene.70011
|2 doi
024 7 _ |a pmid:39797559
|2 pmid
024 7 _ |a pmc:PMC11724196
|2 pmc
024 7 _ |a 1351-5101
|2 ISSN
024 7 _ |a 1468-1331
|2 ISSN
024 7 _ |a altmetric:172947985
|2 altmetric
037 _ _ |a DZNE-2025-00122
041 _ _ |a English
082 _ _ |a 610
100 1 _ |a Lischewski, Stella Andrea
|0 0000-0003-1165-9153
|b 0
245 _ _ |a Longitudinal analysis of anthropometric measures over 5 years in patients with Friedreich ataxia in the EFACTS natural history study.
260 _ _ |a Oxford [u.a.]
|c 2025
|b Wiley-Blackwell
336 7 _ |a article
|2 DRIVER
336 7 _ |a Output Types/Journal article
|2 DataCite
336 7 _ |a Journal Article
|b journal
|m journal
|0 PUB:(DE-HGF)16
|s 1737366252_5000
|2 PUB:(DE-HGF)
336 7 _ |a ARTICLE
|2 BibTeX
336 7 _ |a JOURNAL_ARTICLE
|2 ORCID
336 7 _ |a Journal Article
|0 0
|2 EndNote
520 _ _ |a Friedreich ataxia is a rare neurodegenerative disorder caused by frataxin deficiency. Both underweight and overweight occur in mitochondrial disorders, each with adverse health outcomes. We investigated the longitudinal evolution of anthropometric abnormalities in Friedreich ataxia and the hypothesis that both weight loss and weight gain are associated with faster disease progression.Participants were drawn from the European Friedreich's Ataxia Consortium for Translational Studies (EFACTS). Age- and sex-specific BMI and height scores were calculated using the KIGGS-BMI percentiles for children. Height correction was applied for scoliosis. Longitudinal data were analysed using linear mixed effects models and incremental standard deviation scores and growth mixture models identified subclasses with varying BMI trajectories.Five hundred and forty-three adults and fifty-nine children were assessed for up to 5 years. In children, severe underweight (26%), underweight (7%), severe short stature (16%) and short stature (23%) were common. The corrected BMI percentile was stable in children, although 48% had negative incremental BMI scores over 1 year and 63% over 3 years versus 10%/year in a normal reference cohort. Overweight was common in adults (19%), with a slight increase in BMI over time. Longer GAA repeat size was linked to lower BMI in adults. Weight trajectory was not associated with ataxia progression in adults.Significant anthropometric abnormalities were identified, with underweight and short stature prevalent in children and overweight in adults. These findings highlight the need for regular nutritional monitoring and interventions to manage underweight in children and promote healthy weight in adults.
536 _ _ |a 353 - Clinical and Health Care Research (POF4-353)
|0 G:(DE-HGF)POF4-353
|c POF4-353
|f POF IV
|x 0
588 _ _ |a Dataset connected to CrossRef, PubMed, , Journals: pub.dzne.de
650 _ 7 |a Friedreich ataxia
|2 Other
650 _ 7 |a body height
|2 Other
650 _ 7 |a body mass index
|2 Other
650 _ 7 |a natural history
|2 Other
650 _ 7 |a underweight
|2 Other
650 _ 2 |a Humans
|2 MeSH
650 _ 2 |a Friedreich Ataxia: epidemiology
|2 MeSH
650 _ 2 |a Friedreich Ataxia: complications
|2 MeSH
650 _ 2 |a Friedreich Ataxia: physiopathology
|2 MeSH
650 _ 2 |a Male
|2 MeSH
650 _ 2 |a Female
|2 MeSH
650 _ 2 |a Longitudinal Studies
|2 MeSH
650 _ 2 |a Adult
|2 MeSH
650 _ 2 |a Child
|2 MeSH
650 _ 2 |a Adolescent
|2 MeSH
650 _ 2 |a Disease Progression
|2 MeSH
650 _ 2 |a Body Mass Index
|2 MeSH
650 _ 2 |a Young Adult
|2 MeSH
650 _ 2 |a Thinness: epidemiology
|2 MeSH
650 _ 2 |a Middle Aged
|2 MeSH
650 _ 2 |a Anthropometry
|2 MeSH
650 _ 2 |a Overweight: epidemiology
|2 MeSH
650 _ 2 |a Overweight: complications
|2 MeSH
700 1 _ |a Konrad, Kerstin
|b 1
700 1 _ |a Dogan, Imis
|b 2
700 1 _ |a Didszun, Claire
|b 3
700 1 _ |a Costa, Ana Sofia
|b 4
700 1 _ |a Schawohl, Sara Annabelle
|b 5
700 1 _ |a Giunti, Paola
|0 0000-0003-3508-4788
|b 6
700 1 _ |a Parkinson, Michael H
|b 7
700 1 _ |a Mariotti, Caterina
|0 0000-0003-2405-3564
|b 8
700 1 _ |a Nanetti, Lorenzo
|b 9
700 1 _ |a Durr, Alexandra
|b 10
700 1 _ |a Ewenczyk, Claire
|b 11
700 1 _ |a Boesch, Sylvia
|b 12
700 1 _ |a Nachbauer, Wolfgang
|b 13
700 1 _ |a Klopstock, Thomas
|0 P:(DE-2719)2810704
|b 14
700 1 _ |a Stendel, Claudia
|0 P:(DE-2719)2812141
|b 15
|u dzne
700 1 _ |a de Rivera Garrido, Francisco Javier Rodríguez
|0 P:(DE-HGF)0
|b 16
700 1 _ |a Schöls, Ludger
|0 P:(DE-2719)2810795
|b 17
|u dzne
700 1 _ |a Fleszar, Zofia
|0 P:(DE-2719)9000074
|b 18
|u dzne
700 1 _ |a Klockgether, Thomas
|0 P:(DE-2719)2810314
|b 19
|u dzne
700 1 _ |a Grobe-Einsler, Marcus
|0 P:(DE-2719)9001510
|b 20
700 1 _ |a Giordano, Ilaria
|0 P:(DE-2719)2811662
|b 21
|u dzne
700 1 _ |a Rai, Myriam
|b 22
700 1 _ |a Pandolfo, Massimo
|b 23
700 1 _ |a Schulz, Jörg B
|b 24
700 1 _ |a Reetz, Kathrin
|0 0000-0002-9730-9228
|b 25
700 1 _ |a group, EFACTS study
|b 26
|e Collaboration Author
700 1 _ |a Indelicato, Elisabetta
|b 27
|e Contributor
700 1 _ |a Ampros, Matthias
|b 28
|e Contributor
700 1 _ |a Gellera, Cinzia
|b 29
|e Contributor
700 1 _ |a Mongelli, Alessia
|b 30
|e Contributor
700 1 _ |a Castaldo, Anna
|b 31
|e Contributor
700 1 _ |a Fichera, Mario
|b 32
|e Contributor
700 1 _ |a Bertini, Enrico
|b 33
|e Contributor
700 1 _ |a Vasco, Gessica
|b 34
|e Contributor
700 1 _ |a Biet, Marie
|b 35
|e Contributor
700 1 _ |a Monin, Marie Lorraine
|b 36
|e Contributor
700 1 _ |a Holtbernd, Florian
|b 37
|e Contributor
700 1 _ |a Brcina, Nikolina
|b 38
|e Contributor
700 1 _ |a Hohenfeld, Christian
|b 39
|e Contributor
700 1 _ |a Radelfahr, Florentine
|b 40
|e Contributor
700 1 _ |a Bischoff, Almut T
|b 41
|e Contributor
700 1 _ |a Hayer, Stefanie N
|b 42
|e Contributor
700 1 _ |a Koutsis, Georgios
|b 43
|e Contributor
700 1 _ |a Breza, Marianthi
|b 44
|e Contributor
700 1 _ |a Palau, Francesc
|b 45
|e Contributor
700 1 _ |a O'Callaghan, Mar
|b 46
|e Contributor
700 1 _ |a Thomas-Black, Gilbert
|b 47
|e Contributor
700 1 _ |a Manso, Katarina
|b 48
|e Contributor
700 1 _ |a Solanky, Nita
|b 49
|e Contributor
700 1 _ |a Labrum, Robyn
|b 50
|e Contributor
773 _ _ |a 10.1111/ene.70011
|g Vol. 32, no. 1, p. e70011
|0 PERI:(DE-600)2020241-6
|n 1
|p e70011
|t European journal of neurology
|v 32
|y 2025
|x 1351-5101
856 4 _ |u https://pub.dzne.de/record/275887/files/DZNE-2025-00122%20SUP.docx
856 4 _ |y OpenAccess
|u https://pub.dzne.de/record/275887/files/DZNE-2025-00122.pdf
856 4 _ |u https://pub.dzne.de/record/275887/files/DZNE-2025-00122%20SUP.doc
856 4 _ |u https://pub.dzne.de/record/275887/files/DZNE-2025-00122%20SUP.odt
856 4 _ |u https://pub.dzne.de/record/275887/files/DZNE-2025-00122%20SUP.pdf
856 4 _ |y OpenAccess
|x pdfa
|u https://pub.dzne.de/record/275887/files/DZNE-2025-00122.pdf?subformat=pdfa
909 C O |o oai:pub.dzne.de:275887
|p openaire
|p open_access
|p VDB
|p driver
|p dnbdelivery
910 1 _ |a Deutsches Zentrum für Neurodegenerative Erkrankungen
|0 I:(DE-588)1065079516
|k DZNE
|b 14
|6 P:(DE-2719)2810704
910 1 _ |a Deutsches Zentrum für Neurodegenerative Erkrankungen
|0 I:(DE-588)1065079516
|k DZNE
|b 15
|6 P:(DE-2719)2812141
910 1 _ |a Deutsches Zentrum für Neurodegenerative Erkrankungen
|0 I:(DE-588)1065079516
|k DZNE
|b 17
|6 P:(DE-2719)2810795
910 1 _ |a Deutsches Zentrum für Neurodegenerative Erkrankungen
|0 I:(DE-588)1065079516
|k DZNE
|b 18
|6 P:(DE-2719)9000074
910 1 _ |a Deutsches Zentrum für Neurodegenerative Erkrankungen
|0 I:(DE-588)1065079516
|k DZNE
|b 19
|6 P:(DE-2719)2810314
910 1 _ |a Deutsches Zentrum für Neurodegenerative Erkrankungen
|0 I:(DE-588)1065079516
|k DZNE
|b 20
|6 P:(DE-2719)9001510
910 1 _ |a External Institute
|0 I:(DE-HGF)0
|k Extern
|b 21
|6 P:(DE-2719)2811662
913 1 _ |a DE-HGF
|b Gesundheit
|l Neurodegenerative Diseases
|1 G:(DE-HGF)POF4-350
|0 G:(DE-HGF)POF4-353
|3 G:(DE-HGF)POF4
|2 G:(DE-HGF)POF4-300
|4 G:(DE-HGF)POF
|v Clinical and Health Care Research
|x 0
914 1 _ |y 2025
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0200
|2 StatID
|b SCOPUS
|d 2024-12-12
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0300
|2 StatID
|b Medline
|d 2024-12-12
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)1050
|2 StatID
|b BIOSIS Previews
|d 2024-12-12
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)1190
|2 StatID
|b Biological Abstracts
|d 2024-12-12
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0600
|2 StatID
|b Ebsco Academic Search
|d 2024-12-12
915 _ _ |a JCR
|0 StatID:(DE-HGF)0100
|2 StatID
|b EUR J NEUROL : 2022
|d 2024-12-12
915 _ _ |a DEAL Wiley
|0 StatID:(DE-HGF)3001
|2 StatID
|d 2024-12-12
|w ger
915 _ _ |a WoS
|0 StatID:(DE-HGF)0113
|2 StatID
|b Science Citation Index Expanded
|d 2024-12-12
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0150
|2 StatID
|b Web of Science Core Collection
|d 2024-12-12
915 _ _ |a Creative Commons Attribution CC BY 4.0
|0 LIC:(DE-HGF)CCBY4
|2 HGFVOC
915 _ _ |a OpenAccess
|0 StatID:(DE-HGF)0510
|2 StatID
915 _ _ |a Peer Review
|0 StatID:(DE-HGF)0030
|2 StatID
|b ASC
|d 2024-12-12
915 _ _ |a IF >= 5
|0 StatID:(DE-HGF)9905
|2 StatID
|b EUR J NEUROL : 2022
|d 2024-12-12
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0160
|2 StatID
|b Essential Science Indicators
|d 2024-12-12
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)1110
|2 StatID
|b Current Contents - Clinical Medicine
|d 2024-12-12
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0199
|2 StatID
|b Clarivate Analytics Master Journal List
|d 2024-12-12
920 1 _ |0 I:(DE-2719)1111015
|k Clinical Research (Munich)
|l Clinical Research (Munich)
|x 0
920 1 _ |0 I:(DE-2719)5000005
|k AG Schöls
|l Clinical Neurogenetics
|x 1
920 1 _ |0 I:(DE-2719)1210000
|k AG Gasser
|l Parkinson Genetics
|x 2
920 1 _ |0 I:(DE-2719)1011101
|k Patient Studies (Bonn)
|l Patient Studies (Bonn)
|x 3
920 1 _ |0 I:(DE-2719)1011001
|k Clinical Research (Bonn)
|l Clinical Research Coordination
|x 4
980 _ _ |a journal
980 _ _ |a VDB
980 _ _ |a UNRESTRICTED
980 _ _ |a I:(DE-2719)1111015
980 _ _ |a I:(DE-2719)5000005
980 _ _ |a I:(DE-2719)1210000
980 _ _ |a I:(DE-2719)1011101
980 _ _ |a I:(DE-2719)1011001
980 1 _ |a FullTexts


LibraryCollectionCLSMajorCLSMinorLanguageAuthor
Marc 21